ARTA
GNMK

A.R.T. Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

A.R.T. Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-16,427
Closed -$79K – 1223
2019
Q4 		$79K Sell
16,427
-4,200
-20% -$23.2K ﹤0.01% 1232
2019
Q3 		$125K Buy
+20,627
New +$129K 0.01% 1249
2019
Q2 		– Sell
-64,911
Closed -$460K – 1755
2019
Q1 		$460K Buy
+64,911
New +$427K 0.03% 769
2018
Q4 		– Sell
-51,113
Closed -$375K – 1808
2018
Q3 		$375K Sell
51,113
-15,200
-23% -$112K 0.02% 960
2018
Q2 		$423K Sell
66,313
-63,901
-49% -$422K 0.02% 979
2018
Q1 		$708K Buy
130,214
+80,024
+159% +$398K 0.03% 802
2017
Q4 		$209K Buy
+50,190
New +$302K 0.01% 1149
2017
Q2 		– Sell
-31,700
Closed -$406K – 1845
2017
Q1 		$406K Sell
31,700
-25,100
-44% -$302K 0.02% 885
2016
Q4 		$695K Buy
56,800
+41,300
+266% +$490K 0.04% 612
2016
Q3 		$182K Buy
+15,500
New +$150K 0.06% 502
2016
Q2 		– Sell
-59,748
Closed -$314K – 1741
2016
Q1 		$314K Sell
59,748
-24,500
-29% -$136K 0.01% 1033
2015
Q4 		$653K Buy
+84,248
New +$647K 0.03% 746
2015
Q2 		– Sell
-39,923
Closed -$518K – 1806
2015
Q1 		$518K Buy
+39,923
New +$522K 0.02% 897
2014
Q4 		– Sell
-21,799
Closed -$195K – 1754
2014
Q3 		$195K Buy
+21,799
New +$235K 0.01% 1112
2014
Q2 		– Sell
-35,350
Closed -$351K – 1621
2014
Q1 		$351K Buy
+35,350
New +$439K 0.02% 928
2013
Q3 		– Sell
-56,705
Closed -$586K – 1566
2013
Q2 		$586K Buy
+56,705
New +$782K 0.02% 808

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

A.R.T. Advisors's GNMK Position: Q1 2020 in Review

A.R.T. Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2020, closing a stake of 16,427 shares — an estimated $79K sold.

A.R.T. Advisors first reported a position in GNMK in Q2 2013 and held it in 16 quarters. The position peaked at $708K in Q1 2018. 110 funds tracked by Wall St. Rank hold GNMK as of Q1 2020.

  • A.R.T. Advisors reported no remaining GenMark Diagnostics, Inc position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 16,427 GenMark Diagnostics, Inc shares in Q1 2020, an estimated $79K.
  • A.R.T. Advisors first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 16 quarters.
  • A.R.T. Advisors's GenMark Diagnostics, Inc position peaked at $708K in Q1 2018.
  • 110 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.